乳腺癌前更年期妇女的卵巢功能抑制决策和吸收:混合方法分析分析
N L Henry1, L K Monkman2, K Griffith3
1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA. norahh@umich.edu.
Breast cancer research and treatment
|February 23, 2026
概括
患者教育和量身定制的支持对于优化乳腺癌治疗中的卵巢功能抑制 (OFS) 决策至关重要. 了解患者因素和改善沟通可以提高OFS的使用和坚持.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 患者为中心的护理
背景情况:
- 卵巢功能抑制 (OFS) 用于减少激素受体阳性乳腺癌的复发风险.
- 然而,OFS与毒性和低于预期的利用率有关.
研究的目的:
- 为了确定影响OFS注射使用的患者因素.
- 了解与OFS相关的决策过程和教育需求.
主要方法:
- 融合混合方法研究涉及30名参与者.
- 半结构面试和问卷评估了共享的决策和药物信仰.
主要成果:
- 关键主题包括需要对OFS副作用进行更多教育.
- 减少复发风险的愿望推动了OFS的使用.
- 一些患者认为OFS注射是暂时的,更喜欢卵巢切除术.
- 缺乏强有力的医生建议影响了OFS启动.
结论:
- 量身定制的患者支持对于优化OFS决策至关重要.
- 应该探索教育策略,如同行导师和决策辅助工具.
更多相关视频
相关概念视频
Hormonal Control of the Ovarian Cycle
7.1K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.1K
Oogenesis
70.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.4K
Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793


